Swiss-Chinese Life Sciences Forum
Fostering Collaboration in a Changing World
Get ready for an exciting adventure at the Swiss Chinese Life Sciences Forum on 14th May 2024! The forum is co-organized in collaboration of SCCC, Basel Area Business & Innovation and VISCHER AG.
Switzerland is home to a highly innovative life science cluster. Many multinational corporations, as well as a network of smaller companies and startups have operations in Switzerland, mostly in the Basel Area.
In China, the life science industry has been growing at an accelerated pace and brings a growing number of innovative drugs and services to the European market.
We're diving into how Swiss and Chinese pharmaceutical companies team up to succeed in a changing world. Plus, we'll explore how biopharma companies get the support they need in both China and Switzerland. Learn all about expanding into new markets and investing in promising start-ups.
Guest speakers from Swiss as well as Chinese companies will present insights into the following topics:
Unleashing innovation: Set up operations in Switzerland to foster partnerships between Swiss and Chinese biopharma companies.
Building bridges: Discover infrastructure support for biopharma pioneers in both nations.
Expanding horizons: Navigate market changes and unlock investment potential for startups.
Come and join us as we connect with colleagues from Switzerland and China to explore new possibilities in the changing world of life sciences.
Register here: VISCHER Event Swiss-Chinese Life Sciences Forum 2024
9.00 a.m. Doors open/arrival
9.30 a.m. Welcome and Speaker Introduction
9.40 a.m. Presentations
Providing Infrastructure to innovative biopharma companies in China and Switzerland, Ms. Xi Zhang , CEO, Superlab Suisse
How to navigate for expansion to Europe in challenging times, Mr. Bruno Delie, General Manager, Luye Pharma Europe AG
Unleashing innovation: international collaboration China-USA/Boston-Europe/Basel, Ms. Lin Jin, Co-founder, President, CATUG
Mastering the drug approval process in China, Dr. Jiansong Yang, Chief Science Officer, Tigermed
10.55 a.m. Panel discussion and Q&A
12.00 p.m. Apéro at Superlab Suisse